TrialJournal of diabetes science and technology2023
Participant Experiences of Low-Dose Empagliflozin Use as Adjunct Therapy to Hybrid Closed Loop: Findings From a Randomized Controlled Trial.
Melissa-Rosina Pasqua et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.